Those guidelines were passed by Cabinet on Thursday and will take effect on Jan. 1, said official at Ministry of Health and Welfare.
Friday Amgen gave its answer No.
The company said it wouldn't make drug available to 48 patients who had participated in its clinical trials.
Up to 500 animal rights activists marched through England's historic city of Oxford to protest against a controversial animal research lab under construction at famed university nearby.
The agency said that safety issues would preclude drug's being given to new patients but that it would consider allowing Amgen to resume treating existing patients.
